DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR TOLTERODINE TARTRATE
» See Plans and Pricing
All Clinical Trials for Tolterodine Tartrate
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00143377 | Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OAB | Completed | Pfizer | Phase 4 | 2004-09-01 | The purpose of this study is to evaluate the effectiveness of Detrusitol (tolterodine tartrate) SR, 4 mg once daily, on patient's perception of the symptoms of overactive bladder and which of these bothersome symptoms are improved with treatment. |
| NCT00293839 | Efficacy and Tolerability of DITROPAN XL (Oxybutynin Chloride) Versus DETROL LA (Tolterodine Tartrate) in Treatment of Overactive Bladder | Completed | Alza Corporation, DE, USA | Phase 3 | 1969-12-31 | The purpose of this study is to compare the efficacy of DITROPAN® XL (oxybutynin chloride) Extended-Release Tablets and DETROL® LA (tolterodine tartrate extended-release capsules) in the reduction of urge urinary incontinence episodes during a 12-week treatment period in patients with overactive bladder. The secondary objective is to compare the tolerability of DITROPAN® XL (oxybutynin chloride) and DETROL® LA (tolterodine tartrate) during a 12-week treatment period. |
| NCT00454740 | Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder | Completed | Astellas Pharma Inc | Phase 3 | 2004-06-01 | To evaluate the efficacy of 5 and10mg solifenacin succinate in patients with urgency who have OAB syndrome (urgency, with or without urge incontinence, usually with frequency and nocturia) and wish to switch from tolterodine tartrate extended release to solifenacin succinate due to lack of sufficient improvement in urgency episodes |
| NCT00768521 | A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107) | Completed | Merck Sharp & Dohme Corp. | Phase 1 | 2008-09-01 | This study will design an alternative urodynamic platform to better evaluate treatment effects of medications for overactive bladder. Part II is dependent on results of Part I and may not be conducted. |
| NCT01089751 | Efficacy of Sanctura XR (Trospium Chloride) for Reducing Overactive Bladder Symptoms in Female Subjects Refractory to Detrol LA (Tolterodine Tartrate Extended Release) Daily | Completed | Allergan | Phase 4 | 2010-03-01 | This study will investigate the safety and efficacy of Sanctura XR (trospium chloride) daily in reducing urgency, urinary frequency and urinary urge incontinence in female patients with incontinence refractory to Detrol LA (tolterodine tartrate extended release) 4 mg therapy. |
| NCT01175382 | Combined Behavioral and Drug Treatment of Overactive Bladder in Men | Completed | University of Alabama at Birmingham | Phase 2/Phase 3 | 2010-07-01 | The primary aim of this project is to evaluate the effectiveness of combined behavioral + drug therapy compared to behavioral treatment alone and drug therapy alone as a way to improve outcomes in the treatment of OAB symptoms in men. We hypothesize that combined therapy will result in better outcomes than either behavioral or drug therapy alone. The second aim is to compare two methods of implementing combined therapy: simultaneously as initial therapy vs. stepped therapy, in which therapies are combined following initial behavioral or drug therapy alone. The third aim is to examine the costs and cost-effectiveness of combined behavioral + drug therapy compared to behavioral or drug therapy alone. |
| NCT01512004 | Propiverine Hydrochloride Extended-Release Capsule for Overactive Bladder | Completed | APOGEPHA Arzneimittel GmbH | Phase 3 | 2010-01-01 | The purpose of this Phase III study is to evaluate the efficacy and safety of Propiverine Hydrochloride Extended-Release Capsule in the treatment of overactive bladder in Chinese population with urgent micturition, frequent micturition and/or urge urinary incontinence. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Tolterodine Tartrate
Condition Name
Clinical Trial Locations for Tolterodine Tartrate
Trials by Country
Clinical Trial Progress for Tolterodine Tartrate
Clinical Trial Phase
Clinical Trial Sponsors for Tolterodine Tartrate
Sponsor Name
